EUVIMEDEUVIMED entdecken
Crossref

Correlation of Heterozygote risk, Pathological risk and lifetime risk with Clinicopathologic Features in Iranian breast cancer patients

Sahar Ardalan, Mahtab Dastpak, Fatemeh Homayee Shandiz, Narjes Forouzanfar, Ariane Sadr-Nabavi

The Cancer Press · 2017

DOI: 10.15562/tcp.45 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Cancer Press, 2017. Verfasst von Sahar Ardalan und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ardalan, S., Dastpak, M., Shandiz, F. H., Forouzanfar, N., & Sadr-Nabavi, A. (2017). Correlation of Heterozygote risk, Pathological risk and lifetime risk with Clinicopathologic Features in Iranian breast cancer patients. The Cancer Press. https://doi.org/10.15562/tcp.45

Vancouver

Ardalan S, Dastpak M, Shandiz FH, Forouzanfar N, Sadr-Nabavi A. Correlation of Heterozygote risk, Pathological risk and lifetime risk with Clinicopathologic Features in Iranian breast cancer patients. The Cancer Press. 2017. doi:10.15562/tcp.45

BibTeX
@article{Ardalan2017,
  author = {Ardalan, Sahar and Dastpak, Mahtab and Shandiz, Fatemeh Homayee and Forouzanfar, Narjes and Sadr-Nabavi, Ariane},
  title = {Correlation of Heterozygote risk, Pathological risk and lifetime risk with Clinicopathologic Features in Iranian breast cancer patients},
  journal = {The Cancer Press},
  year = {2017},
  doi = {10.15562/tcp.45}
}
Kostenlos starten →